首页> 外文期刊>Disability and rehabilitation. >Functioning and disability in adults with myotonic dystrophy type 1.
【24h】

Functioning and disability in adults with myotonic dystrophy type 1.

机译:成人1型肌强直性营养不良的功能和残疾

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To provide a comprehensive description of functioning and disability with regard to stages of disease progression in adults with myotonic dystrophy type 1 (DM1). Further to explore associations of measures of manual dexterity and of walking capacity with measures of activities of daily living (ADL) and participation in social and lifestyle activities. METHODS: Seventy persons with DM1 underwent examinations, tests and answered questionnaires. Stages of disease progression were based on the muscular impairment rating scale. RESULTS: Overweight, cardiac dysfunctions, respiratory restrictions, fatigue and/or low physical activity levels were found in approximately 40% of those with DM1. Over 75% had muscle impairments, and activity limitations in manual dexterity and walking. Dependence in personal and instrumental ADL was found in 16% and 39%, respectively, and participation restrictions in social and lifestyle activities in 52%. The presence of concurrent body-function impairments, activity limitations and participation restrictions was high. Significant differences were found in muscle impairment, manual dexterity, mobility, ADL and social and lifestyle activities with regard to disease progression. Cut-off values in measures of manual dexterity and walking capacity associated to functioning are proposed. CONCLUSION: This information can be used for developing clinical practise and for health promotion for persons with DM1.
机译:目的:提供关于成年型强直性营养不良(DM1)成人疾病进展阶段的功能和残疾的全面描述。进一步探索手敏捷度和步行能力的度量与日常生活活动(ADL)和参与社交和生活方式活动的度量之间的联系。方法:70名患有DM1的人接受了检查,测试和回答问卷。疾病进展的阶段基于肌肉损伤等级量表。结果:大约40%的DM1患者发现超重,心脏功能障碍,呼吸限制,疲劳和/或低体力活动水平。超过75%的患者有肌肉损伤,以及手部敏捷和步行活动受限。个人和工具性ADL的依赖分别为16%和39%,社交和生活方式活动的参与限制为52%。并发的身体功能障碍,活动限制和参与限制的存在很高。在疾病进展方面,在肌肉损伤,手巧,活动能力,ADL以及社交和生活方式活动方面发现了显着差异。提出了与功能相关的手敏捷度和步行能力量度的临界值。结论:该信息可用于发展DM1患者的临床实践和促进健康。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号